Background: Cigarette smoking is a risk factor for several diseases including 2
INTRODUCTION 1
Cigarette smoke is a complex aerosol that consists of thousands of chemical compounds. 2
Some of the smoke constituents have been identified as carcinogens by International 3
Agency for Research on Cancer (IARC) (1) . Additionally, smoking is considered as an 4 independent risk factor for atherosclerosis (2) and coronary heart disease (CHD) (3). 5
Numerous studies have shown that cigarette smoking is associated with inflammation 6 (4-7), oxidative stress (8, 9) and platelet activation (10). There is much evidence to 7 suggest that atherosclerosis is an inflammatory disease (11, 12). Increased risks of 8 cardiovascular disease (CVD) are associated with elevated white blood cell (WBC) count 9 (13,14), high sensitivity C-reactive protein (hs-CRP ) (13,15), fibrinogen (13, 16, 17) , and 10 von Willebrand factor (18), which have been considered as markers of low grade 11 systemic inflammation. WBC count is a marker of inflammation and has been found to 12 be an independent predictor for future coronary events (19.20) . Several studies have 13 reported a positive association of WBC counts with smoking (21-23). However, little is 14 cerebral infarction (30) and CVD risk in aspirin-resistant patients (31). The level of 11-1 dehTxB 2 has been reported to be higher in smokers as compared to nonsmokers (27). 2
Switching from smoking cigarettes to transdermal nicotine patch (32) or smoking 3 cessation leads to decreased urinary 11-dehTxB 2 excretion (33). 4
5
Biomarkers of exposure (BOE) represents either a chemical compound or its metabolite 6 that reflect the internal dose of exposure to tobacco constituents (34). Biomarkers of 7 potential harm (BOPH) represent the changes in any levels of the biological system 8 resulted from exposure to harmful substances (34). Although the systemic responses to 9 noxious stimuli often result in elevation of these biomarker levels, bilateral changes are 10 also seen in many situations as the results of homeostatic mechanisms. The role of 11 individual smoke constituents on smoking related diseases has not been fully 12 understood, particularly given that cigarette smoke is a complex mixture of numerous 13 compounds, thereby making it difficult to identify the role of specific constituents in 14 smoking related diseases. Tar is often considered a composite mixture of cigarette 15 smoke constituents. Tar yield is a smoking-machine derived estimate calculated by 16 subtracting the amount of water and nicotine from the total particulate matter obtained 17 biomarkers of potential harm (BOPH) using the data from a population based, multi-1 center, observational study, the Total Exposure Study (TES) (38, 39). The BOE analyzed 2 in this study included nicotine equivalents (NE -Nicotine and its five major metabolites: 3 nicotine-glucuronide, cotinine and its glucuronide, trans-3'-hydroxycotinine and its 4 glucuronide), which has been estimated to reflect about 90% of the nicotine absorbed 5 (40); 4-methylnitrosamino-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (total 6 NNAL), which are metabolites of the particulate-phase smoke constituent NNK, a 7 tobacco specific nitrosamine; 1-hydroxypyrene (1-OHP) and its glucuronides and sulfates, 8 metabolites of pyrene, a surrogate for polycyclic aromatic hydrocarbons; 3-9 hydroxypropylmercapturic acid (3-HPMA), a metabolite of acrolein; 10 monohydroxybutenyl-mercapturic acid (MHBMA), a metabolite of 1,3-butadiene; and 11 carboxyhemoglobin (COHb), a marker of carbon monoxide exposure. The BOPH for 12 inflammation, lipid oxidation and platelet activation included WBC, hs-CRP, fibrinogen, 13
von Willebrand factor, 8-epiPGF 2α, and 11-dehTxB 2 . 14
MATERIALS AND METHODS 15

Study Design 16
The Total Exposure Study (TES) was a cross-sectional, observational, multi-center 17 ambulatory study. Detailed aspects of the study design has been previously reported 18 by immunonephelometry, using a Dade Behring Nephelometer II instrument. Subjects 1 with hs-CRP values >10.0 mg/L were excluded for possible acute inflammations other 2 than cardiovascular causes. Fibrinogen was measured in plasma by a photometric light-3 scattering technique using the MLA-1600 instrument (Medical Laboratory Automation, 4
Inc., Pleasantville, NY). Plasma von Willebrand factor was analyzed using a commercially 5 available antigen activity enzyme immunoassay kit (Diagnostica Stago, Inc., Parsippany, 6 NJ). COHb in whole blood was measured spectrophotometrically as percent saturation 7 (%). 8 9
Urine Biomarkers 10
Nicotine Equivalents (NE: Nicotine and its 5 major metabolites, nicotine-N-glucuronide, 11 cotinine, cotinine-N-glucuronide, trans-3'-hydroxycotinine, and trans-3'-12 hydroxycotinine-O-glucuronide), total NNAL, 1-OHP, 3-HPMA, 8-epi PGF 2α and 11-13 dehTxB 2 were analyzed as previously described (27,38). 14 15
Statistical Analysis 16
Stepwise Regression Model was used to examine the differences in WBC, hs-CRP, 17 fibrinogen, vWF, 8-epi PGF 2α and 11-dehTxB 2 between adult smokers and nonsmokers, 18 adjusted for age, gender, race and body mass index (BMI). In the models, the response 19 variables were BOPH levels, and the factors were smoking status, age category (21-34, The values of a BOE in adult smokers were categorized by quartiles, and the 1 corresponding values of BOPH were calculated at each BOE quartile. Percent differences 2 in mean BOPH in reference to the mean BOPH in the first quartile were calculated as: 3 (BOPH qi -BOPH q1 )/BOPH q1 x 100, where BOPH qi is the mean value of BOPH in subjects 4 whose BOE levels were within the i th quartile (i = 2, 3 or 4); BOPH q1 is the mean value of 5 BOPH in subjects whose BOE levels were in the first quartile. 6
7
The association between number of cigarettes smoked per day (CPD: 1-10, 11-20, 21-8 30, >31), and each BOPH was assessed using a linear trend analysis. Least-squared 9 means for a factor were obtained assuming that the levels of other factors were equally 10 represented. Results of this type of analysis were considered statistically significant at p 11 < 0.05. 12
13
Multiple regression stepwise elimination method was used to examine the effects of 14 biomarkers of exposure (NE, total NNAL, COHb, total 1-OHP, 3-HPMA and MHBMA) in 15 relationship with the BOPHs (WBC, hs-CRP, fibrinogen, vWF, 8-epi PGF 2α and 11-dehTxB 2 ) 16 in adult smokers. The relationship between machine measured tar yield (determined by 17 the Cambridge Filter Test Method) grouped into four categories T1 (<2.9 mg), T2 (3.0 -18 6.9 mg), T3 (7.0 -12.9 mg) and T4 (> 13.0 mg), and BOPHs was also tested in a separate data transformation was applied. In the models, number of years smoked, NE, total 1 NNAL, COHb, total 1-OHP, 3-HPMA and MHBMA were continuous variables. Gender, 2 race, BMI and tar category were categorical variables. Races other than White or Black 3
were excluded from the analysis due to the small sample sizes. F values for the variables 4 from the final models were used to rank the variables' importance in determining the 5 variability of the biomarkers of potential harm in the model (41). In the regression 6 models, variables were considered statistically significant at p < 0.10. 7
8
SAS
® for Windows release 9.1.3 (SAS Institute, Cary, NC) was used for conducting the 9 statistical analyses. SAS procedure Proc REG was used for the stepwise regression and 10
Proc GLM was used for the analysis of covariance and trend analysis, respectively. It was 11 also used for least squared mean comparison between the tar categories. 12
13
RESULTS
14
The study enrolled 4,706 subjects, of which 3,585 adult smokers and 1,077 nonsmokers 15 were evaluable. Of the evaluable subjects, 174 smokers and 17 nonsmokers did not 16 have complete urine sample, and 302 smokers and 69 nonsmokers had their hs-CRP 17 greater than 10 mg/dl. These subjects were not included in the final analysis for the 18 corresponding biomarkers. Demographic and smoking characteristics of the study 19 population are summarized in Table 1 . The least square mean values of BOPH in adult smokers and nonsmokers by smoking 1 status and smoking intensity are presented in Tables 2a and 2b . The quartile ranges of 2 BOE in adult smokers are presented in Table 3 . 3 4
Biomarkers of Inflammation 5
Mean WBC count, hs-CRP, fibrinogen and von Willebrand factor levels were statistically 6 significantly higher in adult smokers compared to nonsmokers (Table 2a ). In adult 7 smokers, WBC, hs-CRP and fibrinogen showed a positive correlation with CPD (p < 0.05) 8 (Table 2b) . When grouped by subjects' quartiles of NE and total NNAL, mean WBC, hs-9 CRP and fibrinogen in adult smokers were positively correlated with subjects' quartile 10 values of NE (p < 0.0001 for trend) (Figure 1a and b) . Compared to the first quartile, the 11 mean values of WBC, hs-CRP and fibrinogen in subjects in the 4 th quartile were 17, 18, 12 and 7% higher for NE and 24, 37 and 11% higher for total NNAL, respectively. vWF 13 showed a negative correlation with subjects' quartile values of NE (p = 0.0123 for trend), 14 with a 5% differences between the 4 th and the first quartiles of NE. A 4% difference in 15 vWF between the 4 th and first quartiles of total NNAL was observed, but it did not reach 16 statistical significance (p=0.218 for trend) (Figure 1a and b) . 17
Mean WBC and hs-CRP of subjects whose 1-OHP levels were in the highest quartile were 18 less than 12% higher as compared to the values in the first quartile, although they were BMI was the highest ranking statistically significant factor for WBC, hs-CRP and 5 fibrinogen. NE was not a statistically significant factor in the model for hs-CRP. In the 6 model for vWF, smoking duration was the most important statistically significant factor 7 and gender, COHb and MHBMA were not statistically significant factors ( Table 4) . 8
Collectively, the statistically significant factors in the final stepwise regression model 9
with BOEs explained 12%, 20%, 16% and 5% of the variability in the levels of WBC, hs-10 CRP, fibrinogen and vWF, respectively. In the models exploring the relationship 11 between machine measured tar categories and these inflammatory biomarkers, tar 12 category was a statistically significant factor for WBC, hs-CRP and fibrinogen but not 13 vWF. The relative ranking of importance based on F-values was lower compared to 14 other factors in the model. The model with tar category explained 6%, 19%, 15% and 5% 15 of the variability in the levels of WBC, hs-CRP, fibrinogen and vWF respectively. Upon 16 comparison of the least square mean (LSMean) across the four tar category groups, 17 statistically significant (p<0.05) higher levels of WBC, hs-CRP and fibrinogen were 18 observed in the T4 category (>13.0 mg) group as compared to the T1 category (0-2.9 mg) 19 group, as well as in the T4 as compared to the T2 category (3.0-6.9 mg) groups for WBC 20 and fibrinogen. In adult smokers, mean 8-epiPGF 2α was statistically significantly higher than nonsmokers, 3
and showed a positive correlation with CPD (p = 0.0003 for trend) ( Table 2b) . 4
Mean 8-epiPGF 2α in adult smokers was positively correlated with subjects' quartile 5 values of NE, total NNAL, 1-OHP, 3-HPMA and MHBMA (p < 0.0001 for trend, Figure 1a -6 f), and were negatively correlated with COHb (p = 0.0003 for trend) . Mean 8-epiPGF 2α in 7 subjects whose NE, total NNAL, 1-OHP, COHb, 3-HPMA and MHBMA levels were in the 8 4 th quartile were 48, 53, 61, 12, 50 and 30% higher, respectively, compared to those 9 whose BOE levels were in the first quartile (Figure 1a-f) . The mean 8-epiPGF 2α in 10 subjects whose COHb levels were in the 4 th quartile were 2% and 3% lower as compared 11 to those whose COHb levels were in the 2 nd and 3 rd quartiles, respectively (Figure 1d) . 12
In the regression model, BMI was the highest ranked statistically significant factor. The 13 regression model with BOEs explained 22% of the variability in urinary 8-epiPGF 2α , 14 (Table 4) . 8-epiPGF 2α was inversely correlated with COHb (Coefficient = -91.06) and 15 smoking duration (-5.12 -8.57). Machine measured tar category was a statistically 16 significant factor and was ranked after BMI and Gender in the regression model with tar 17 categories. This model explained 10% of the variability in urinary 8-epiPGF 2α . The 18
LSMean values of 8-epiPGF 2α were statistically significantly (p<0.05) higher in the T4 tar 19 category group as compared to the T1, T2 and T3 tar category groups, respectively, as 20 well as in the T3 category group as compared to the T2 tar category groups. 
Biomarker for Platelet Activation 1
Mean 11-dehTxB 2 was statistically significantly higher in adult smokers than in 2 nonsmokers, and was positively correlated with CPD (p = 0.0284 for trend) ( Table 2) . 3 4 Mean 11-dehTxB 2 in adult smokers was positively correlated with subjects' quartile 5 values of NE, total NNAL, COHb, 1-OHP, 3-HPMA and MHBMA (p = 0.0002 for trend for 6 COHb, p < 0.0001 for the rest) (Figure 1a-f) . Mean 11-dehTxB 2 in subjects whose NE, 7 total NNAL, 1-OHP, COHb,3-HPMA and MHBMA levels were in the 4 th quartile were 46, 8 47, 76, 14, 46, and 29% higher, respectively, compared to those whose BOE levels were 9 in the first quartile (Figure 1a-f) . 10
11
In the stepwise regression model, gender was the highest ranked statistically significant 12 factor for 11-dehTxB 2 . 11-dehTxB 2 was inversely correlated with COHb (-40.95) and 13 smoking duration (-5.01). Models with BOEs explained 13% of the variability in urinary 14 11-dehTxB 2 ( Table 4) . 15
Tar category was a statistically significant factor in the model investigating tar and was 16 ranked after Gender and BMI, explaining 7% of the variability in urinary 11-dehTxB 2 
. The 17
LSMean values of 11-dehTxB 2 were statistically significantly (p<0.05) higher in the T4 tar 18 category group as compared to the T1, T2 and T3 tar category groups, respectively. In this cross-sectional, population-based study involving a total of 3,585 adult smokers 1 and 1,077 nonsmokers, we were able to investigate relationships between demographic 2 characteristics, biomarkers of exposure and biomarkers of potential harm associated 3 with inflammation, oxidative stress and platelet activation. 4
5
The role of inflammation in the development of coronary atherosclerosis has been 6 established in the literature. In the present study, we found that WBC count correlated 7 with biomarkers of exposure to nicotine, tobacco specific nitrosamine, 1,3-butadiene 8 and carbon monoxide. These observations along with the trend analysis with number of 9 cigarettes smoked per day are suggestive of an association between overall smoke 10 exposure and WBC count. The relative ranking of the statistically significant parameters, 11
in the stepwise regression model, varied for the two tobacco specific biomarkers, NE 12 and total NNAL. This phenomenon may be due to the differences in the half-life 13 (approximately 20 hrs for NE (40) and ~10-18 days for total NNAL (42) of these 14 constituents. It is possible that due to its long elimination rate, NNAL tracks consistently 15 with the BOPHs and therefore, might be considered a measure of an average level of 16 long-term exposure rather than daily variations of exposure due to possible variation in 17 cigarette consumption which is better measured by NE. It cannot be ruled out that the 18 association between tobacco specific BOEs and BOPHs could be due to colinearity of a 19 particular constituent with total smoke exposure or a surrogate measure of another 20 smoke constituent not investigated. The weak correlations between the BOPHs and 21 both the demographic and BOEs limits the ability to make any general inferences. 
1
The observations of higher hs-CRP levels in adult smokers in this study are similar to 2 previous reports (5). Our results show that in adult smokers, BMI was the highest 3 ranking parameter associated with hs-CRP levels (43-45). Interestingly, NE was not a 4 significant factor in the final model for hs-CRP, and total NNAL was listed as the 4 th most 5 important factor after BMI, smoking duration and gender. The statistically significant 6 parameters included in the final stepwise regression model were different between hs-7 CRP and WBC (Table 4) This is not surprising since the tar yield is an indirect, machine derived estimate. In 7 contrast, the BOEs are measured in the body fluids and are more direct measures of 8 systemic exposure. Smoking has been suggested to be one of the factors playing a role 9 in oxidative stress through its generation of reactive oxygen species (49). 8-epiPGF 2α is 10 an in vivo measurement of oxidative stress and has been reported to be elevated in 11 smokers (50). We found that 8-epiPGF 2α levels were inversely correlated with smoking 12 duration and COHb. The inverse correlation between 8-epiPGF 2α and COHb is supported 13 by recent evidence from animal studies that suggested CO may have antioxidant 14 properties (51). Exhaled CO and 8-isoprostane were found to be elevated in patients 15 with severe asthma (52) and cystic fibrosis (53), suggesting a homeostatic mechanism of 16 CO production in response to oxidative stress. BMI was the highest ranking factor in the 17 The results of the current study indicate that 11-dehydro-thromboxin B 2 excretion is 1 elevated in adult smokers, which is in accordance with the findings in the literature that 2 thromboxane biosynthesis in smokers is increased (54). This biomarker was found to be 3 inversely correlated with smoking duration and COHb. The inverse association with 4 smoking duration suggests that an age related effect could be primarily influencing this 5 relationship. The inverse association with COHb, however, is not clear. A protective 6 effect of CO on platelet activation has been reported in aortic transplantation animals 7 that were treated with CO-releasing molecules (55). Sato et al (56) found that treatment 8 of animals with 250-500 ppm CO prevented platelet activation and coronary thrombosis. 9
In the current study however, the effect of COHb on 11-dehTx B 2 is small (based on the F 10 value in the model). 11
12
Although this study provides valuable insight regarding the role of cigarette smoke 13 exposure on disease related mechanistic pathways, there are some limitations that may 14 need to be considered. This is a cross-sectional study, therefore causality could not be 15 established between the biomarkers of exposure and the biomarkers of potential harm. The association between the biomarkers of potential harm and the biomarkers of 1 exposure reflect the overall effect of cigarette smoking as well as many additional 2 internal and external factors such as BMI and those not included in this analysis such as 3 lifestyle, genetics etc. In addition the fact that cigarette smoke is a complex mixture of 4 thousands of chemicals further complicates our ability to unravel the role of individual 5 smoke constituents. The possibility of collinearity among smoke constituents or classes 6 of chemicals should be kept in mind when interpreting the relationships of the 7 biomarkers of potential harm and biomarkers of exposure. Our estimates on the 8 importance of the correlation between BOE and BOPH showed that BMI was ranked the 9 most important factor in four of the six BOPH in models when BOEs were tested. It 10 should be noted that the variables in the final model collectively could only explain a 11 small proportion of the variability in BOPH . The R-squared values ranged between 0.05 12 in the model for vWF and 0.22 for 8-epiPGF 2α , suggesting that the BOE together with 13 demographics and smoking duration account for only a small portion of the variability in 14 the BOPHs investigated. Furthermore, in several models, considering the relative rank 15 order of importance based on F-value, the BOE were usually several-fold lower than the 16 highest ranking variable, e.g., the F value in the model of 8-epiPGF 2α was 171 for BMI, 17 and 72 for total NNAL. This rank order highlights the complexity of the disease 18 mechanisms and suggests that important confounders such as BMI must be taken into 19 consideration when investigating the association between BOE and BOPHs. 
